BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 20616968)

  • 1. Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme.
    Anaky MF; Duvignac J; Wemin L; Kouakoussui A; Karcher S; Touré S; Seyler C; Fassinou P; Dabis F; N'Dri-Yoman T; Anglaret X; Leroy V
    Bull World Health Organ; 2010 Jul; 88(7):490-9. PubMed ID: 20616968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.
    Auld AF; Tuho MZ; Ekra KA; Shiraishi RW; Mohamed F; Kouakou JS; Ettiègne-Traoré V; Sabatier J; Essombo J; Rivadeneira ED; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    Pediatr Infect Dis J; 2014 Nov; 33(11):1134-40. PubMed ID: 25093975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009.
    Desmonde S; Coffie P; Aka E; Amani-Bosse C; Messou E; Dabis F; Alioum A; Ciaranello A; Leroy V
    BMC Infect Dis; 2011 Jun; 11():182. PubMed ID: 21699728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d'Ivoire.
    Desmonde S; Avit D; Petit J; Amorissani Folquet M; Eboua FT; Amani Bosse C; Dainguy E; Mea V; Timite-Konan M; Ngbeché S; Ciaranello A; Leroy V
    PLoS One; 2016; 11(12):e0166466. PubMed ID: 27935971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis in human immunodeficiency virus-infected children starting antiretroviral therapy in Côte d'Ivoire.
    Auld AF; Tuho MZ; Ekra KA; Kouakou J; Shiraishi RW; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):381-7. PubMed ID: 24670690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Task-sharing with nurses to enhance access to HIV treatment in Côte d'Ivoire.
    McNairy ML; Bashi JB; Chung H; Wemin L; Lorng MA; Brou H; Nioble C; Lokossue A; Abo K; Achi D; Ouattara K; Sess D; Sanogo PA; Ekra A; Ettiegne-Traore V; Diabate CJ; Abrams EJ; El-Sadr WM
    Trop Med Int Health; 2017 Apr; 22(4):431-441. PubMed ID: 28101954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention and Predictors of Attrition Among HIV-infected Children on Antiretroviral Therapy in Côte d'Ivoire Between 2012 and 2016.
    Touré F; Etheredge GD; Brennan C; Parris K; Diallo MO; Ouffoue AF; Ekra A; Prao H; Assamoua NV; Gnongoue C; Kone F; Koffi C; Kamagaté F; Rivadeneira E; Carpenter D
    Pediatr Infect Dis J; 2023 Apr; 42(4):299-304. PubMed ID: 36689665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral treatment response of HIV-infected children after prevention of mother-to-child transmission in West Africa.
    Ndondoki C; Dicko F; Ahuatchi Coffie P; Kassi Eboua T; Ekouevi DK; Kouadio K; Edmond Aka A; Malateste K; Dabis F; Amani-Bosse C; Toure P; Leroy V;
    J Int AIDS Soc; 2014; 17(1):18737. PubMed ID: 24894377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medium-term survival, morbidity and immunovirological evolution in HIV-infected adults receiving antiretroviral therapy, Abidjan, Côte d'Ivoire.
    Seyler C; Anglaret X; Dakoury-Dogbo N; Messou E; Touré S; Danel C; Diakité N; Daudié A; Inwoley A; Maurice C; Tonwe-Gold B; Rouet F; N'Dri-Yoman T; Salamon R;
    Antivir Ther; 2003 Oct; 8(5):385-93. PubMed ID: 14640385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Côte d'Ivoire: a prospective cohort study.
    Harouna AM; Amorissani-Folquet M; Eboua FT; Desmonde S; N'Gbeche S; Aka EA; Kouadio K; Kouacou B; Malateste K; Bosse-Amani C; Ahuatchi Coffie P; Leroy V;
    BMC Infect Dis; 2015 Aug; 15():317. PubMed ID: 26248711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Côte d'Ivoire national HIV counseling and testing program for tuberculosis patients: implementation and analysis of epidemiologic data.
    Abouya L; Coulibaly IM; Wiktor SZ; Coulibaly D; N'kragbo M; N'gbo A; Zahui H; Touré K; Jacquemin K; San-Koffi M; Ackah A; Sassan-Morokro M; Maurice C; Whitaker JP; De Cock KM; Greenberg AE
    AIDS; 1998 Mar; 12(5):505-12. PubMed ID: 9543449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d'Ivoire: A model-based analysis.
    Ouattara EN; MacLean RL; Danel C; Borre ED; Gabillard D; Huang M; Moh R; Paltiel AD; Eholié SP; Walensky RP; Anglaret X; Freedberg KA
    PLoS One; 2019; 14(6):e0219068. PubMed ID: 31247009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short communication: Severe symptomatic hyperlactatemia among HIV type 1-infected adults on antiretroviral therapy in Côte d'Ivoire.
    Minga A; Lewden C; Dohoun L; Abo Y; Emieme A; Coulibaly A; Salamon R; Eholié S; Anglaret X; Danel C;
    AIDS Res Hum Retroviruses; 2010 Sep; 26(9):991-5. PubMed ID: 20707728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04.
    Walenda C; Kouakoussui A; Rouet F; Wemin L; Anaky MF; Msellati P
    J Trop Pediatr; 2009 Jun; 55(3):170-6. PubMed ID: 19066169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.
    Losina E; Touré H; Uhler LM; Anglaret X; Paltiel AD; Balestre E; Walensky RP; Messou E; Weinstein MC; Dabis F; Freedberg KA; ;
    PLoS Med; 2009 Oct; 6(10):e1000173. PubMed ID: 19859538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of undiagnosed HIV among children in South Africa, Côte d'Ivoire and Zimbabwe: a model-based analysis to inform paediatric HIV screening programmes.
    McCann NC; Stanic T; Penazzato M; Flanagan CF; Abrams EJ; Dugdale CM; Johnson LF; Neilan AM; Davies MA; Freedberg KA; Fassinou P; Doherty M; Essajee S; Mushavi A; Soeteman DI; Ciaranello AL
    J Int AIDS Soc; 2022 Dec; 25(12):e26045. PubMed ID: 36519674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS.
    Renner LA; Dicko F; Kouéta F; Malateste K; Gueye RD; Aka E; Eboua TK; Azondékon A; Okomo U; Touré P; Ekouévi D; Leroy V;
    J Int AIDS Soc; 2013 Sep; 16(1):18024. PubMed ID: 24047928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjusting mortality for loss to follow-up: analysis of five ART programmes in sub-Saharan Africa.
    Brinkhof MW; Spycher BD; Yiannoutsos C; Weigel R; Wood R; Messou E; Boulle A; Egger M; Sterne JA;
    PLoS One; 2010 Nov; 5(11):e14149. PubMed ID: 21152392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Côte d'Ivoire Initiating Antiretroviral Therapy.
    Houghtaling L; Moh R; Abdou Chekaraou M; Gabillard D; Anglaret X; Eholié SP; Zoulim F; Danel C; Lacombe K; Boyd A
    AIDS Res Hum Retroviruses; 2018 May; 34(5):439-445. PubMed ID: 29466862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire.
    Anglaret X; Minga A; Gabillard D; Ouassa T; Messou E; Morris B; Traore M; Coulibaly A; Freedberg KA; Lewden C; Ménan H; Abo Y; Dakoury-Dogbo N; Toure S; Seyler C;
    Clin Infect Dis; 2012 Mar; 54(5):714-23. PubMed ID: 22173233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.